BCMA
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of BCMA/CD70 CAR-T Therapy for Refractory cSLE (NCT06934447) | The Children's Hospital of Zhejiang University School of Medicine | 2025-04-25 |
| A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma. (NCT05228470) | Pfizer | 2021-12-21 |
Track BCMA automatically
Every clearance here is in the API, with alerts when new ones post.